Voya Investment Management LLC Lexicon Pharmaceuticals, Inc. Transaction History

Voya Investment Management LLC

$78.9 Billion
Q4 2024

A detailed history of Voya Investment Management LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 38,418 shares of LXRX stock, worth $13,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,418

Previous 38,418 -0.0%

Holding current value

$13,830

Previous $60,000 53.33%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Feb 07, 2025	SELL	$1.51 - $2.39 $1,854 - $2,934	-1,228 Reduced 3.1%	38,418 $60,000
Q3 2024 Nov 14, 2024	SELL	$1.51 - $2.39 $1,854 - $2,934	-1,228 Reduced 3.1%	38,418 $60,000
Q2 2024 Feb 07, 2025	BUY	$1.54 - $2.28 $16,442 - $24,343	10,677 Added 36.86%	39,646 $66,000
Q2 2024 Dec 03, 2024	BUY	$1.54 - $2.28 $1,891 - $2,799	1,228 Added 3.2%	39,646 $66,000
Q2 2024 Aug 14, 2024	BUY	$1.54 - $2.28 $16,442 - $24,343	10,677 Added 36.86%	39,646 $66,000
Q1 2024 Feb 07, 2025	SELL	$1.3 - $3.58 $12,283 - $33,827	-9,449 Reduced 24.6%	28,969 $69,000
Q1 2024 Dec 06, 2024	SELL	$1.3 - $3.58 $12,283 - $33,827	-9,449 Reduced 24.6%	28,969 $69,000
Q1 2024 May 15, 2024	SELL	$1.3 - $3.58 $10,907 - $30,036	-8,390 Reduced 22.46%	28,969 $69,000
Q2 2023 Feb 07, 2025	BUY	$2.15 - $3.49 $10,057 - $16,326	4,678 Added 14.31%	37,359 $85,000
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $10,057 - $16,326	4,678 Added 14.31%	37,359 $85,000
Q1 2023 Feb 07, 2025	SELL	$1.99 - $2.68 $11,416 - $15,375	-5,737 Reduced 14.93%	32,681 $79,000
Q3 2022 Feb 07, 2025	SELL	$1.94 - $3.43 $11,129 - $19,677	-5,737 Reduced 14.93%	32,681 $78,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $12,280 - $21,711	6,330 Added 24.02%	32,681 $78,000
Q2 2022 Aug 15, 2022	SELL	$1.31 - $2.69 $6,063 - $12,452	-4,629 Reduced 14.94%	26,351 $49,000
Q1 2022 May 16, 2022	BUY	$1.95 - $3.89 $3,517 - $7,017	1,804 Added 6.18%	30,980 $65,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $8,644 - $13,977	2,269 Added 8.43%	29,176 $115,000
Q2 2021 Aug 16, 2021	BUY	$4.12 - $5.87 $26,808 - $38,196	6,507 Added 31.9%	26,907 $124,000
Q1 2021 May 17, 2021	SELL	$3.45 - $9.09 $5,816 - $15,325	-1,686 Reduced 7.63%	20,400 $120,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $3.67 $9,622 - $33,631	9,164 Added 70.92%	22,086 $76,000
Q2 2020 Aug 14, 2020	SELL	$1.75 - $2.3 $15,758 - $20,711	-9,005 Reduced 41.07%	12,922 $26,000
Q4 2019 Feb 14, 2020	BUY	$3.16 - $5.15 $14,577 - $23,756	4,613 Added 26.64%	21,927 $91,000
Q2 2018 Aug 14, 2018	SELL	$7.8 - $13.69 $18,985 - $33,321	-2,434 Reduced 12.33%	17,314 $208,000
Q1 2018 May 15, 2018	SELL	$7.86 - $11.39 $8.2 Million - $11.9 Million	-1,043,263 Reduced 98.14%	19,748 $169,000
Q4 2017 Feb 14, 2018	SELL	$8.77 - $12.28 $821,556 - $1.15 Million	-93,678 Reduced 8.1%	1,063,011 $10.5 Million
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $14.1 Million - $18.9 Million	1,156,689	1,156,689 $14.2 Million

Others Institutions Holding LXRX

# of Institutions

133

Shares Held

245M

Call Options Held

52K

Put Options Held

178K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $67.9M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Lexicon Pharmaceuticals, Inc. Transaction History